Previous close | 6.6000 |
Open | 5.0000 |
Bid | 4.8000 |
Ask | 5.7000 |
Strike | 125.00 |
Expiry date | 2025-01-17 |
Day's range | 5.0000 - 5.0000 |
Contract range | N/A |
Volume | |
Open interest | 178 |
Per the findings of the pivotal BLUE-C study, the Cologuard Plus test of Exact Sciences stands out for its high sensitivity at a specificity of 94%.
Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today unveiled its MiSeq™ i100 Series of sequencing systems, delivering unparalleled benchtop speed and simplicity to advance next-generation sequencing (NGS) for labs.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.